Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial
Primary Purpose
Fever, Heart Rate, Fetal (FHR)
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Acetaminophen 975 mg
Sponsored by
About this trial
This is an interventional treatment trial for Fever focused on measuring Fetal tachycardia, Fever in labor, Acetaminophen, Non reassuring fetal status
Eligibility Criteria
Inclusion Criteria:
- Term pregnancy
- Singleton pregnancy
- Pregnancy with cephalic presentation
- Pregnancy in active phase labor
- Fetal tachycardia
Exclusion Criteria:
- Acetaminophen allergy
- Clinical chorioamnionitis
- Maternal fever
- Non-reassuring fetal status or fetal heart rate abnormalities requiring cesarean delivery
- Previous cesarean delivery
- Multifetal gestation
- Breech presentation
- Known fetal anomaly
- Known contraindication to vaginal delivery
Sites / Locations
- New York Hospital Medical Center of Queens
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Active Comparator
Arm Label
1
2
Arm Description
Acetaminophen 975 mg once
Outcomes
Primary Outcome Measures
Maternal Body Temperature 90 Minutes After Randomization
Fever in labor is identified,consenting and randomization occurs, either acetaminophen is given or no medication is given, then 90 minutes later maternal temperature is recorded.
Baseline Fetal Heart Rate (FHR) After Treatment
Secondary Outcome Measures
Temperature Difference Before and After Treatment
Maternal temperature difference before randomization and 90 minutes after randomization in degrees Centigrade
Rate of Cesarean Delivery
Rate of cesarean delivery
Rate of Determination of Non-reassuring Fetal Status
Non-reassuring fetal status is when cesarean delivery or operative vaginal delivery (forceps or vacuum) are performed for fetal heart rate abnormalities.
Rate of Subsequent Development of Maternal Fever
Rate of subsequent development of maternal fever, i.e., the number of participants who developed fever.
Rate of Diagnosis of Clinical Chorioamnionitis
Rate of diagnosis of clinical chorioamnionitis, i.e., the number of participants who developed chorioamnionitis.
Rate of Neonatal Sepsis
the number of participants who developed neonatal sepsis
Full Information
NCT ID
NCT00377832
First Posted
September 14, 2006
Last Updated
September 5, 2013
Sponsor
Weill Medical College of Cornell University
1. Study Identification
Unique Protocol Identification Number
NCT00377832
Brief Title
Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial
Official Title
Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial
Study Type
Interventional
2. Study Status
Record Verification Date
September 2013
Overall Recruitment Status
Terminated
Why Stopped
Poor recruitment and lack of funding
Study Start Date
July 2007 (undefined)
Primary Completion Date
December 2010 (Actual)
Study Completion Date
December 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Weill Medical College of Cornell University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The most common cause of fetal tachycardia is maternal fever. Fetal tachycardia often precedes the maternal fever, and fetal tachycardia confounds the interpretation of electronic fetal monitoring (EFM), increasing the rate of cesarean delivery for non-reassuring fetal status (NRFS). Our hypothesis is that treatment of fetal tachycardia with acetaminophen will significantly lower maternal body temperature and significantly lower baseline fetal heart rate (FHR). The importance is that interpretation of EFM will improve, thus allowing for a decrease in cesarean delivery for NRFS.
Detailed Description
This trial is a randomized, non-placebo controlled, assessment of whether acetaminophen can lower maternal temperature and baseline fetal heart rate in laboring patients with fetal tachycardia.
Term singleton cephalic pregnancies in active phase labor (spontaneous or induced) with fetal tachycardia will be recruited. Patient will be excluded for:
Exclusion criteria (prior to randomization):
Acetaminophen allergy
Clinical chorioamnionitis
Maternal fever
Non-reassuring fetal status (NRFS), which is the designation for fetal heart rate abnormalities requiring cesarean delivery
Previous cesarean delivery
Multifetal gestation
Breech presentation
Known fetal anomaly
Known contraindication to vaginal delivery
Primary outcome measures are:
Maternal body temperature (oral) 90 minutes after treatment
Baseline FHR
Secondary outcome measures are:
Temperature difference before and after treatment
Rate of cesarean delivery
Rate of determination of NRFS
Rate of subsequent development of maternal fever
Rate of diagnosis of clinical chorioamnionitis
Rate of neonatal sepsis
Power calculation Internal data collection at our institution of 53 patients showed a mean decrease in temperature of patients in labor with fever receiving acetaminophen is 0.3 degrees C measured an average (mean) of 90 minutes after administration of acetaminophen. Mean oral temperature before acetaminophen was 38.32, SD 0.33. Mean oral temperature after acetaminophen was 38.03, SD 0.85.
Sample size calculation shows that 27 patients are needed in each group to show significant difference using alpha 5% and beta 50%.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fever, Heart Rate, Fetal (FHR)
Keywords
Fetal tachycardia, Fever in labor, Acetaminophen, Non reassuring fetal status
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
13 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
No Intervention
Arm Title
2
Arm Type
Active Comparator
Arm Description
Acetaminophen 975 mg once
Intervention Type
Drug
Intervention Name(s)
Acetaminophen 975 mg
Other Intervention Name(s)
Tylenol
Intervention Description
Acetaminophen 975 mg by mouth once only
Primary Outcome Measure Information:
Title
Maternal Body Temperature 90 Minutes After Randomization
Description
Fever in labor is identified,consenting and randomization occurs, either acetaminophen is given or no medication is given, then 90 minutes later maternal temperature is recorded.
Time Frame
90 minutes
Title
Baseline Fetal Heart Rate (FHR) After Treatment
Time Frame
90 minutes
Secondary Outcome Measure Information:
Title
Temperature Difference Before and After Treatment
Description
Maternal temperature difference before randomization and 90 minutes after randomization in degrees Centigrade
Time Frame
90 minutes
Title
Rate of Cesarean Delivery
Description
Rate of cesarean delivery
Time Frame
Labor--up to 24 hours
Title
Rate of Determination of Non-reassuring Fetal Status
Description
Non-reassuring fetal status is when cesarean delivery or operative vaginal delivery (forceps or vacuum) are performed for fetal heart rate abnormalities.
Time Frame
Labor--up to 24 hours
Title
Rate of Subsequent Development of Maternal Fever
Description
Rate of subsequent development of maternal fever, i.e., the number of participants who developed fever.
Time Frame
Labor--up to 24 hours
Title
Rate of Diagnosis of Clinical Chorioamnionitis
Description
Rate of diagnosis of clinical chorioamnionitis, i.e., the number of participants who developed chorioamnionitis.
Time Frame
Labor--up to 24 hours
Title
Rate of Neonatal Sepsis
Description
the number of participants who developed neonatal sepsis
Time Frame
7 days
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Term pregnancy
Singleton pregnancy
Pregnancy with cephalic presentation
Pregnancy in active phase labor
Fetal tachycardia
Exclusion Criteria:
Acetaminophen allergy
Clinical chorioamnionitis
Maternal fever
Non-reassuring fetal status or fetal heart rate abnormalities requiring cesarean delivery
Previous cesarean delivery
Multifetal gestation
Breech presentation
Known fetal anomaly
Known contraindication to vaginal delivery
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniel W Skupski, MD
Organizational Affiliation
Weill Medical College of Cornell University, New York Hospital Medical Center of Queens
Official's Role
Principal Investigator
Facility Information:
Facility Name
New York Hospital Medical Center of Queens
City
Flushing
State/Province
New York
ZIP/Postal Code
11355
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial
We'll reach out to this number within 24 hrs